Hematology/Oncology

Top Story

Targeted radiation reduces mortality for early-stage lung cancer

Targeted radiation reduces mortality for early-stage lung cancer
February 20, 2018
In the Journals Plus

Study identifies racial disparities in multiple myeloma treatment, outcomes

February 20, 2018
Outcomes for patients with multiple myeloma treatment appeared to substantially improve in recent years, according to findings published in Cancer. However, racial…
Meeting News

Gene mutations may improve prognosis models for certain patients with leukemia subtype

February 20, 2018
ATLANTA — Contrary to previous research, treatment with hypomethylating agents seem to only partially negate the poor prognosis of certain mutations among patients…
Meeting News

Age, immunomodulator use increase cancer risk in IBD patients

February 20, 2018
Older patients with inflammatory bowel disease who have recently taken immunomodulators were more likely to have or develop cancer, according to research presented at…
In the Journals Plus

Fluids extend survival at end of life for patients with cancer

February 20, 2018
Patients with cancer at end of life who received assisted hydration survived nearly 1.5 days longer than those who did not receive fluids, according to study results. …
More Headlines »
CME

Targeted Therapies for Metastatic HCC: Multidisciplinary Perspectives on the Latest Clinical Advances

This activity is supported by an educational grant from Bayer Healthcare Pharmaceuticals, Inc.

The incidence of hepatocellular carcinoma (HCC) continues to increase in the United States. Management of patients…
More »
Video
Meeting News

VIDEO: Stereotactic radiotherapy preferred for brain metastases from renal cell carcinoma

November 5, 2017
More »
Resource Centers
BMT Tandem Meetings

BMT Tandem Meetings

CME CPE

Addressing Common Patient Concerns Regarding Biosimilars

This activity is supported by an educational grant from Pfizer, Inc.

As more biosimilars are approved for use in the United States, greater emphasis is needed on educating patients about…
More »
Current Issues
View the Current Issue
HemOnc Today